参考文献/References:
[1]de Oliveira CV,Horvat N,Testagrossa LA,et al.Etiological profile and main imaging findings in patients with granulomatous diseases who underwent lung biopsy[J].Eur J Radiol Open,2021(8):100325.[2]Grosu HB,Ost DE,Morice RC,et al.Mediastinal Granulomatous Inflammation and Overall Survival in Patients with a History of Malignancy[J].Ann Am Thorac Soc,2015,12(10):1534-1541. [3]Chopra A,Avadhani V,Tiwari A,et al.Granulomatous lung disease: clinical aspects[J].Expert Rev Respir Med,2020,14(10):1045-1063. [4]Mukhopadhyay S,Farver CF,Vaszar LT,et al.Causes of pulmonary granulomas: a retrospective study of 500 cases from seven countries[J].J Clin Pathol,2012,65(1):51-57. [5]Al-Harbi A,Al-Otaibi S,Abdulrahman A,et al.Lung granuloma: A clinicopathologic study of 158 cases[J].Ann Thorac Med,2017,12(4):278-281.[6]Nazarullah A,Nilson R,Maselli DJ,et al.Incidence and aetiologies of pulmonary granulomatous inflammation: a decade of experience[J].Respirology,2015,20(1):115-121.[7]Lederer DJ,Martinez FJ.Idiopathic Pulmonary Fibrosis[J].N Engl J Med,2018,378(19):1811-1823.[8]Harding E.WHO global progress report on tuberculosis elimination[J].Lancet Respir Med,2020,8(1):19. [9]中华医学会结核病学分会,结核病病理学诊断专家共识编写组.中国结核病病理学诊断专家共识[J].中华结核和呼吸杂志,2017,40(6):419-425. [10]Romdhane E,Rammeh S,Riahi H,et al.The Value of Histology in the Diagnosis of Tuberculous Spondylodiscitis[J].J Clin Rheumatol,2020,26(2):63-66. [11]Narang S,Solanki A,Kashyap S,et al.Utility of fine needle aspiration cytology to comprehend the pathogenesis of extrapulmonary tuberculosis[J].Diagn Cytopathol,2016,44(2):98-102. [12]Krishna M,Gole SG.Comparison of Conventional Ziehl-Neelsen Method of Acid Fast Bacilli with Modified Bleach Method in Tuberculous Lymphadenitis[J].J Cytol,2017,34(4):188-192.[13]娄丽萍,张文迪.石蜡包埋组织实时荧光定量PCR技术在结核病诊断中的应用[J].锦州医科大学学报,2019,40(3):74-76[14]李雪,孟禹彤,周翔,等.结核病病理诊断的新方法研究[J].诊断病理学杂志,2020,27(5):300-305.[15]Donohue MJ.Increasing nontuberculous mycobacteria reporting rates and species diversity identified in clinical laboratory reports[J].BMC Infect Dis,2018,18(1):163.[16]Hermansen TS,Ravn P,Svensson E,et al.Nontuberculous mycobacteria in Denmark, incidence and clinical importance during the last quarter-century[J].Sci Rep,2017,7(1):6696. [17]Yu X,Liu P,Liu G,et al.The prevalence of non-tuberculous mycobacterial infections in mainland China: Systematic review and meta-analysis[J].J Infect,2016,73(6):558-567.[18]Huang HL,Cheng MH,Lu PL,et al.Epidemiology and Predictors of NTM Pulmonary Infection in Taiwan-a Retrospective, Five-Year Multicenter Study[J].Sci Rep,2017,7(1):16300. [19]李多,房坤,王珏,等.非结核分枝杆菌肺病的CT分型及其临床特征分析(附132例报告)[J].中国防痨杂志,2019,41(2):202-209.[20]Ciet P,Serra G,Bertolo S,et al.Assessment of CF lung disease using motion corrected PROPELLER MRI: a comparison with CT[J].Eur Radiol,2016,26(3):780-787. [21]Campo M.What is Nontuberculous Mycobacteria(NTM) Disease[J].Am J Respir Crit Care Med,2017(195):17-18.[22]中华医学会结核病学分会.非结核分枝杆菌病诊断与治疗指南(2020年版)[J].中华结核和呼吸杂志,2020,43(11):918-946. [23]王翠萍,邵汇琳,王澎,等.组织病理学诊断的肺真菌病187例菌种分布的回顾性分析[J].中华结核和呼吸杂志,2021,44(1):28-31. [24]林鹏程,叶君如,周颖,等.接受抗真菌药物治疗肺隐球菌病患者胸部CT和隐球菌荚膜抗原滴度的动态观察[J].中华医学杂志,2019,99(26):2036-2041. [25]傅顺金,许攀峰,周华,等.52例肺隐球菌病的临床及影像特点与隐球菌荚膜抗原检测结果的关系[J].中华医院感染学杂志,2018,28(22):3397-3400,3409. [26]徐建平,宋蓉蓉,赵洁婷,等.肺隐球菌病37例临床病理分析[J].临床与实验病理学杂志,2017,33(9):1041-1043.[27]李晓光,谢宗玉,康厚艺,等.原发性肺隐球菌病的CT影像和病理表现[J].蚌埠医学院学报,2019,44(11):1513-1517.[28]邸小青,甘思远,叶瑞芳,等.肺原发性隐球菌病患者临床病理及影像学特征分析[J].中国病原生物学杂志,2019,14(6):639-642.[29]Sun KS,Tsai CF,Chen SC,et al.Correction: Galactomannan Testing and the Incidence of Invasive Pulmonary Aspergillosis: A 10-Year Nationwide Population-Based Study in Taiwan[J].PLoS One,2016,11(6):e0156566.[30]潘玲,卢岳虹,宋策,等.支气管镜下肺泡灌洗液半乳甘露聚糖试验联合(1，3)-β-D葡聚糖检测对肺曲霉菌病的诊断价值[J].中国内镜杂志,2019,25(8):5-9.[31]张健雄,李云霄,王浩彦.66例结节病首发表现与首诊科室回顾分析[J].心肺血管病杂志,2018,37(1):29-32.[32]中华医学会呼吸病学分会间质性肺疾病学组,中国医师协会呼吸医师分会间质性肺疾病工作委员会.中国肺结节病诊断和治疗专家共识[J].中华结核和呼吸杂志,2019,42(9):685-693.[33]Spagnolo P,Rossi G,Trisolini R,et al.Pulmonary sarcoidosis[J].Lancet Respir Med,2018,6(5):389-402.[34]Aleksoniene R,Zeleckiene I,Mataciūnas M,et al.Relationship between radiologic patterns, pulmonary function values and bronchoalveolar lavage fluid cells in newly diagnosed sarcoidosis[J].J Thorac Dis,2017,9(1):88-95.[35]Ramos-Casals M,Retamozo S,Sisó-Almirall A,et al.Clinically-useful serum biomarkers for diagnosis and prognosis of sarcoidosis[J].Expert Rev Clin Immunol,2019,15(4):391-405.[36]Li CW,Tao RJ,Zou DF,et al.Pulmonary sarcoidosis with and without extrapulmonary involvement: a cross-sectional and observational study in China[J].BMJ Open,2018,8(2):e018865. [37]Eurelings LEM,Miedema JR,Dalm VASH,et al.Sensitivity and specificity of serum soluble interleukin-2 receptor for diagnosing sarcoidosis in a population of patients suspected of sarcoidosis[J].PLoS One,2019,14(10):e0223897. [38]Sun J,Yang H,Teng J,et al.Determining factors in diagnosing pulmonary sarcoidosis by endobronchial ultrasound-guided transbronchial needle aspiration[J].Ann Thorac Surg,2015,99(2):441-445. [39]Batum O,Katgi N,Ozdemir O,et al.Diagnostic efficacy of EBUS-TBNA in benign diseases in a population with a high prevalence of tuberculosis[J].Diagn Cytopathol,2021,49(3):374-380. [40]Li J,Li C,Li J.Thoracic manifestation of Wegener’s granulomatosis: Computed tomography findings and analysis of misdiagnosis[J].Exp Ther Med,2018,16(1):413-419.[41]Solans-Laqué R,Fraile G,Rodriguez-Carballeira M,et al.Clinical characteristics and outcome of Spanish patients with ANCA-associated vasculitides: Impact of the vasculitis type, ANCA specificity, and treatment on mortality and morbidity[J].Medicine (Baltimore),2017,96(8):e6083. [42]Furuta S,Iwamoto T,Nakajima H.Update on eosinophilic granulomatosis with polyangiitis[J].Allergol Int,2019,68(4):430-436. [43]Trivioli G,Terrier B,Vaglio A.Eosinophilic granulomatosis with polyangiitis: understanding the disease and its management[J].Rheumatology (Oxford),2020,59(Suppl 3):iii84-iii94. [44]张立春,高峰.嗜酸性肉芽肿性多血管炎186例临床荟萃分析[J].中国呼吸与危重监护杂志,2017,16(5):505-508.[45]刘启梁,雷美.首诊误诊为淋巴结核的25例淋巴结恶性肿瘤原因分析[J].临床误诊误治,2020,33(1):8-11.[46]杨春蓉,郑晓丹,胡余昌,等.肺淋巴瘤样肉芽肿5例临床病理分析[J].临床与实验病理学杂志,2016,32(8):924-926,930.[47]Kovacs A,Baksay B,Cserenyecz A,et al.Occurrence of pulmonary rheumatoid nodules following biological therapies[J].Clin Rheumatol,2015(34):1639-1642.[48]何善智,丁菱,王敏,等.类风湿关节炎合并肺部类风湿结节的危险因素分析[J].实用医学杂志,2017,33(10):1665-1668.[49]Chopra A,Avadhani V,Tiwari A,et al.Granulomatous lung disease: clinical aspects[J].Expert Rev Respir Med,2020,14(10):1045-1063. [50]Aubry MC.Necrotizing granulomatous inflammation: what does it mean if your special stains are negative?[J].Mod Pathol,2012(25 Suppl 1):S31-S38. [51]Miao Q,Ma Y,Wang Q,et al.Microbiological Diagnostic Performance of Metagenomic Next-generation Sequencing When Applied to Clinical Practice[J].Clin Infect Dis,2018,67(suppl_2):S231-S240.[52]Chen P,Sun W,He Y.Comparison of the next-generation sequencing (NGS) technology with culture methods in the diagnosis of bacterial and fungal infections[J].J Thorac Dis,2020,12(9):4924-4929.
相似文献/References:
[1]刘德福.肺结核患者痰中结核分枝杆菌检验的临床价值分析[J].医学信息,2018,31(01):151.[doi:10.3969/j.issn.1006-1959.2018.01.059]
LIU De-fu.Clinical Value Analysis of Mycobacterium tuberculosis in Sputum of Patients with
Pulmonary Tuberculosis[J].Medical Information,2018,31(05):151.[doi:10.3969/j.issn.1006-1959.2018.01.059]
[2]陈 波,马晓波,洪国粦.Xpert MTB/RIF技术对结核分枝杆菌的诊断价值[J].医学信息,2019,32(06):172.[doi:10.3969/j.issn.1006-1959.2019.06.056]
CHEN Bo,MA Xiao-bo,HONG Guo-lin.Diagnostic Value of Xpert MTB/RIF Technique for Mycobacterium Tuberculosis[J].Medical Information,2019,32(05):172.[doi:10.3969/j.issn.1006-1959.2019.06.056]
[3]胡立珍,周广信,霍丽丽,等.全自动半巢式实时荧光定量PCR技术检测
BALF诊断肺结核的价值[J].医学信息,2019,32(15):165.[doi:10.3969/j.issn.1006-1959.2019.15.056]
HU Li-zhen,ZHOU Guang-xin,HUO Li-li,et al.Detection of the Value of BALF in the Diagnosis of Pulmonary Tuberculosis by
Automatic Semi-nested Real-time PCR[J].Medical Information,2019,32(05):165.[doi:10.3969/j.issn.1006-1959.2019.15.056]
[4]李 鑫.肺结核合并气管支气管结核危险因素及诊断[J].医学信息,2020,33(01):32.[doi:10.3969/j.issn.1006-1959.2020.01.012]
LI Xin.Risk Factors and Diagnosis of Tuberculosis with Tracheobronchial Tuberculosis[J].Medical Information,2020,33(05):32.[doi:10.3969/j.issn.1006-1959.2020.01.012]
[5]曾冬梅.血清中结核分枝杆菌IgG、IgM抗体检测在肺结核诊断中的应用价值[J].医学信息,2022,35(22):157.[doi:10.3969/j.issn.1006-1959.2022.22.039]
ZENG Dong-mei.The Application Value of Serum Mycobacterium Tuberculosis IgG and IgM Antibody Detection in the Diagnosis of Pulmonary Tuberculosis[J].Medical Information,2022,35(05):157.[doi:10.3969/j.issn.1006-1959.2022.22.039]
[6]徐 玥,王 璞.吸烟对肺结核发病、临床特征及转归的影响[J].医学信息,2021,34(05):54.[doi:10.3969/j.issn.1006-1959.2021.05.016]
XU Yue,WANG Pu.The Effect of Smoking on the Incidence,Clinical Characteristics and Outcome of Tuberculosis[J].Medical Information,2021,34(05):54.[doi:10.3969/j.issn.1006-1959.2021.05.016]
[7]杨晓悦,李毓龙,罗仲秋,等.结合分枝杆菌感染者辅助性Th2型细胞因子IL-4、IL-6、IL-10的水平变化[J].医学信息,2023,36(01):113.[doi:10.3969/j.issn.1006-1959.2023.01.022]
YANG Xiao-yue,LI Yu-long,LUO Zhong-qiu,et al.Changes of Helper Th2 Cytokines IL-4, IL-6 and IL-10 Levels in Patients with Mycobacterium Tuberculosis Infection[J].Medical Information,2023,36(05):113.[doi:10.3969/j.issn.1006-1959.2023.01.022]
[8]于 江,孙 杰,刘凤君.结核分枝杆菌抗原在结核病病理学诊断中的研究进展[J].医学信息,2023,36(08):170.[doi:10.3969/j.issn.1006-1959.2023.08.038]
YU Jiang,SUN Jie,LIU Feng-jun.Research Progress of Mycobacterium Tuberculosis Antigen in Pathological Diagnosis of Tuberculosis[J].Medical Information,2023,36(05):170.[doi:10.3969/j.issn.1006-1959.2023.08.038]
[9]逄亚宁,王 聪,刘 奇,等.结核分枝杆菌BfrA蛋白的生物信息学分析[J].医学信息,2022,35(06):81.[doi:10.3969/j.issn.1006-1959.2022.06.020]
PANG Ya-ning,WANG Cong,LIU Qi,et al.Bioinformatics Analysis of BfrA Protein in Mycobacterium Tuberculosis[J].Medical Information,2022,35(05):81.[doi:10.3969/j.issn.1006-1959.2022.06.020]
[10]高 灿,赵晓彤,程 江.结核分枝杆菌TB10.4蛋白的生物信息学分析[J].医学信息,2023,36(18):1.[doi:10.3969/j.issn.1006-1959.2023.18.001]
GAO Can,ZHAO Xiao-tong,CHENG Jiang.Bioinformatics Analysis of Mycobacterium Tuberculosis TB10.4 Protein[J].Medical Information,2023,36(05):1.[doi:10.3969/j.issn.1006-1959.2023.18.001]